Before accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.
Stock Charts AI Power Rank: 9.3
Power Rank trend -> Rising
Industry: Insurance - Property & Casualty
Follow @stockchartsai on TwitterIn the past 20 trading days, MKL has been trading in a range between $1877.45 and $1718.60 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.
MKL is trading below resistance at $2059.83, about 8% to the upside. There is support at $1838.16 -4% to the downside. If it can break above the resistance, it could have some more upside. If the price starts to turn down and fails to get through this level or enters a yellow zone, we would consider profit taking or exiting the position. If it enters a red zone on the chart we would exit the position.
Markel Corporation $MKL entered a Green zone 9 days ago on the AI powered stock chart. Wall Street analysts have an AVG target price $1849.2, a potential down side of -3.62% from the recent price of 1918.71. The stock is trading 7.56% (potential upside) below its 52 week high of $2063.68 and 28.68 % (potential downside) above its 52 week low of $1491.03 - based on the recent price.
Markel Group Inc, through its subsidiaries, engages in the insurance business in the United States and internationally. It offers general and professional liability, personal lines, marine and energy, specialty programs, and workers' compensation insurance products; and property coverages that include fire, windstorm, hail, water damage, and other property coverages comprising catastrophe-exposed property risks, such as earthquake and wind.
Markel enhances its International War and Terrorism presence in the US with Senior Underwriter hire and Underwriting Support Specialist LONDON , May 14, 2025 /PRNewswire/ -- Markel Insurance, the insurance operations within Markel Group Inc. (NYSE:MKL), today announced that it has made two key appointments to drive further profitable growth across its International War and Terrorism portfolio. In his new position as Senior Underwriter – War and Terrorism, Joshua Watson will be responsible for identifying and underwriting complex risk across the organisation's Stand-Alone Terrorism, Terrorism Liability, Strikes, Riots and Civil Commotion (SRCC) and Active Assailant product suite. Source: PRNewsWire Wed, 14 May 2025 04:00:00 -0400 Sentiment: Neutral |
Markel launches first-of-its-kind affirmative cyber product for collateral war cover LONDON , May 13, 2025 /PRNewswire/ -- Markel Insurance, the insurance operations within Markel Group Inc. (NYSE:MKL), today launched an innovative, specialist cyber product to provide up to US$5 million of cover per risk for indirect losses arising from an act of war. Cyber risks are a significant concern for large organisations, particularly those in sectors including critical infrastructure, technology, finance and energy. Source: PRNewsWire Tue, 13 May 2025 04:30:00 -0400 Sentiment: Neutral |
Markel Group announces redemption of Series A Preferred Shares RICHMOND, Va. , May 7, 2025 /PRNewswire/ -- Markel Group Inc. (NYSE: MKL) will redeem for cash all of its outstanding Series A 6.000% Fixed-Rate Reset Non-Cumulative Preferred Shares, no par value (the Series A Preferred Shares), effective June 1, 2025 (the Redemption Date) at a price of $1,000 per share, which is equal to the per-share liquidation preference of the Series A Preferred Shares. Source: PRNewsWire Wed, 07 May 2025 16:30:00 -0400 Sentiment: Neutral |
Markel launches Clinical Trials products to support clinical trials research, globally LONDON , May 7, 2025 /PRNewswire/ -- Markel Insurance, the insurance operations within Markel Group Inc. (NYSE: MKL), today announced the launch of its Clinical Trials insurance product – underscoring its commitment to providing best-in-class solutions to support clinical trials research and product development on an international scale. The new clinical trials offering provides comprehensive cover to sponsors, researchers and participants throughout all phases of clinical research and is tailored to meet the regulatory requirements of more than 100 territories, ensuring smooth and compliant trial operations, worldwide. Source: PRNewsWire Wed, 07 May 2025 05:00:00 -0400 Sentiment: Neutral |
Velocity Announces Strategic Sale of Velocity Specialty Insurance Company; Oaktree to Fully Exit Nashville, TN, May 05, 2025 (GLOBE NEWSWIRE) -- Velocity HoldCo, LLC (“Velocity” or the “Company”), the former parent company for Velocity Specialty Insurance Company (“VSIC”) and Velocity Risk Underwriters, LLC (“VRU”), announced the sale of VSIC to FM, a leading property mutual insurance company. This transaction follows the earlier sale of VRU to Ryan Specialty (NYSE: RYAN) which together represents a full exit of Oaktree Capital Management, L.P. Source: GlobeNewsWire Mon, 05 May 2025 09:00:00 -0400 Sentiment: Neutral |
Stock Analyzed Each Night
Easily Upload Track Your Stocks
See Lists of Stocks Starting New Trends
The information contained on this website is solely for educational purposes, and does not constitute investment advice. The risk of trading in securities markets can be substantial. By accessing this site, you agree we are not liable, whether in contract, tort (including negligence) or otherwise, in respect of any damage, expense or other loss you may suffer arising out of such information or any reliance you may place upon such information from this site. Stocks, Futures and options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stock, futures and options markets. Don't trade with money you can't afford to lose. This website is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this website. The past performance of any trading system or methodology is not necessarily indicative of future results. Individual results may vary, and testimonials are not claimed to represent typical results. All testimonials are by real people, and may not reflect the typical purchaser’s experience, and are not intended to represent or guarantee that anyone will achieve the same or similar results. HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY, SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.